Dr. Ryan Gentzler, MD
Claim this profileUniversity of Virginia Health System
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
11 reported clinical trials
21 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
Stage III
EGFR positive
2Lung Cancer
Stage IV
Stage III
EGFR positive
Affiliated Hospitals
Clinical Trials Ryan Gentzler, MD is currently running
Monalizumab + Durvalumab + Chemotherapy
for Small Cell Lung Cancer
This trial tests a combination of chemotherapy and immune-boosting drugs in cancer patients who have already received some treatment. The chemotherapy attacks cancer cells directly, while the immune-boosting drugs help the body’s defense system fight the cancer.
Recruiting1 award Phase 212 criteria
LY3537982 + Immunotherapy/Chemotherapy
for Non-Small Cell Lung Cancer
This trial is testing a new drug, LY3537982, combined with standard treatments for patients with advanced lung cancer that have a specific genetic mutation. The goal is to see if this combination works better than the usual treatments alone.
Recruiting1 award Phase 314 criteria
More about Ryan Gentzler, MD
Clinical Trial Related3 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Ryan Gentzler, MD has experience with
- Carboplatin
- Pembrolizumab
- Pemetrexed
- Etoposide
- Atezolizumab
- Durvalumab
Breakdown of trials Ryan Gentzler, MD has run
Non-Small Cell Lung Cancer
Lung Cancer
Small Cell Lung Cancer
- Testing the Addition of an Anti-cancer Drug, Entinostat, to the Usual Chemotherapy and Immunotherapy Treatment (Atezolizumab, Carboplatin and Etoposide) for Previously Untreated Aggressive Lung Cancer That Has Spread
- Monalizumab + Durvalumab + Chemotherapy for Small Cell Lung Cancer
- Iadademstat + Atezolizumab/Durvalumab for Small Cell Lung Cancer
Small Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ryan Gentzler, MD specialize in?
Ryan Gentzler, MD focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Ryan Gentzler, MD currently recruiting for clinical trials?
Yes, Ryan Gentzler, MD is currently recruiting for 6 clinical trials in Charlottesville Virginia. If you're interested in participating, you should apply.
Are there any treatments that Ryan Gentzler, MD has studied deeply?
Yes, Ryan Gentzler, MD has studied treatments such as Carboplatin, Pembrolizumab, Pemetrexed.
What is the best way to schedule an appointment with Ryan Gentzler, MD?
Apply for one of the trials that Ryan Gentzler, MD is conducting.
What is the office address of Ryan Gentzler, MD?
The office of Ryan Gentzler, MD is located at: University of Virginia Health System, Charlottesville, Virginia 22908 United States. This is the address for their practice at the University of Virginia Health System.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.